clenbuterol has been researched along with Carcinoma 256, Walker in 3 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Treatment begins at the 4th day after tumor inoculation, at the 14th day they were killed, glycemia, lacticidemia, glycogen content from liver, soleus and gastrocnemius muscles, tumor mass, body weight and kidney function were determined." | 7.72 | Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats. ( Curi, R; Fabrício, VE; Fernandes, LC; Fernandez, R; Folador, A; Gobbo-Bordon, D; Hirabara, SM; Jakobi, S; Moretto, KD; Piffar, PM; Pinto, GJ; Rohn, TV; Tchaikovski, O; Tosta, E, 2003) |
| " Treatment begins at the 4th day after tumor inoculation, at the 14th day they were killed, glycemia, lacticidemia, glycogen content from liver, soleus and gastrocnemius muscles, tumor mass, body weight and kidney function were determined." | 3.72 | Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats. ( Curi, R; Fabrício, VE; Fernandes, LC; Fernandez, R; Folador, A; Gobbo-Bordon, D; Hirabara, SM; Jakobi, S; Moretto, KD; Piffar, PM; Pinto, GJ; Rohn, TV; Tchaikovski, O; Tosta, E, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piffar, PM | 1 |
| Fernandez, R | 2 |
| Tchaikovski, O | 1 |
| Hirabara, SM | 1 |
| Folador, A | 2 |
| Pinto, GJ | 1 |
| Jakobi, S | 1 |
| Gobbo-Bordon, D | 1 |
| Rohn, TV | 1 |
| Fabrício, VE | 1 |
| Moretto, KD | 1 |
| Tosta, E | 1 |
| Curi, R | 2 |
| Fernandes, LC | 2 |
| Pinto, JA | 1 |
| Bonato, SJ | 1 |
| Aikawa, J | 1 |
| Yamazaki, RK | 1 |
| Pizato, N | 1 |
| Facin, M | 1 |
| Grohs, H | 1 |
| de Oliveira, HH | 1 |
| Naliwaiko, K | 1 |
| Ferraz, AC | 1 |
| Nishiyama, A | 1 |
| Gagic, K | 1 |
| Campagnaro, E | 1 |
| LaBorde, CJ | 1 |
| Edavettal, M | 1 |
| Levine, EA | 1 |
| Potter, BJ | 1 |
| Racey Burns, LA | 1 |
| Burns, AH | 1 |
3 other studies available for clenbuterol and Carcinoma 256, Walker
| Article | Year |
|---|---|
Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats.
Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Body Weight; Cachexia; Carcinoma 256, Walker; Clen | 2003 |
Fish oil supplementation in F1 generation associated with naproxen, clenbuterol, and insulin administration reduce tumor growth and cachexia in Walker 256 tumor-bearing rats.
Topics: Animals; Body Weight; Cachexia; Carcinoma 256, Walker; Clenbuterol; Female; Fish Oils; Insulin; Napr | 2004 |
The effect of clenbuterol and recombinant erythropoietin on tumor growth and the anemia caused by the Walker 256 carcinosarcoma.
Topics: Adrenergic beta-Agonists; Anemia; Animals; Carcinoma 256, Walker; Cell Division; Clenbuterol; Erythr | 1997 |